Login / Signup
The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis.
Matthias Gijsen
Erwin Dreesen
Joost Wauters
Yves Debaveye
Isabel Spriet
Published in:
Intensive care medicine (2022)
Keyphrases
</>
study protocol
phase iii
acute kidney injury
intensive care unit
clinical trial
septic shock
phase ii
gram negative
open label